Management of comorbidities in haemophilia-Reference-Cited by-同舟云学术

Management of comorbidities in haemophilia

Published:2020-06 Issue:S3 Volume:27 Page:37-45
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Kempton Christine L.¹^ORCID,Makris Michael²³^ORCID,Holme Pål Andre⁴⁵^ORCID

Affiliation:

1. Department of Hematology and Medical Oncology and Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory Emory University School of Medicine Atlanta GA USA

2. Department of Infection Immunity and Cardiovascular Disease University of Sheffield Sheffield UK

3. Sheffield Haemophilia and Thrombosis Centre Royal Hallamshire Hospital Sheffield UK

4. Department of Haematology Oslo University Hospital Oslo Norway

5. Institute of Clinical Medicine University of Oslo Oslo Norway

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14013

Reference77 articles.

1. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

2. Haemophilia and ageing

3. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV

4. The natural history of chronic hepatitis C in haemophiliacs

5. Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Socio-demographic Factors and Comorbidities in Adult Hemophilia Patients;Journal of Basic and Clinical Health Sciences;2024-05-31

2. Treatment of thrombotic cardiovascular diseases in people with haemophilia: A Japanese consensus study;Haemophilia;2024-05-23

3. Using evidence‐based co‐design to develop a hybrid delivered exercise intervention that aims to increase confidence to exercise in people with haemophilia;Haemophilia;2024-03-10

4. Emicizumab is efficacious in people with hemophilia A with comorbidities aged ≥50 years: analysis of 4 phase III trials;Research and Practice in Thrombosis and Haemostasis;2024-03

5. Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapy;Haemophilia;2023-10-11